Integral Diagnostics Limited

ASX:IDX Stock Report

Market Cap: AU$518.2m

Integral Diagnostics Management

Management criteria checks 2/4

Integral Diagnostics' CEO is Ian Kadish, appointed in May 2017, has a tenure of 6.83 years. total yearly compensation is A$1.10M, comprised of 71.2% salary and 28.8% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth A$1.24M. The average tenure of the management team and the board of directors is 3.5 years and 1.7 years respectively.

Key information

Ian Kadish

Chief executive officer

AU$1.1m

Total compensation

CEO salary percentage71.2%
CEO tenure6.8yrs
CEO ownership0.2%
Management average tenure3.5yrs
Board average tenure1.7yrs

Recent management updates

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Recent updates

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

Feb 20
Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Dec 14
These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

May 26
Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Feb 28
Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Feb 25
Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Oct 29
Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Sep 13
Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Jun 04
An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

May 14
Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

May 03
Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Apr 16
We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Mar 27
Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

Mar 17
Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Mar 07
The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Feb 25
Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Feb 23
Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Feb 13
Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Feb 03
Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Jan 24
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Jan 14
Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Jan 05
Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Dec 26
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

Dec 17
At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Dec 08
What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Nov 29
Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Nov 19
Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Sep 20
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Sep 11
Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?

Sep 03
Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?

CEO Compensation Analysis

How has Ian Kadish's remuneration changed compared to Integral Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$58m

Sep 30 2023n/an/a

-AU$16m

Jun 30 2023AU$1mAU$782k

AU$25m

Mar 31 2023n/an/a

AU$23m

Dec 31 2022n/an/a

AU$21m

Sep 30 2022n/an/a

AU$18m

Jun 30 2022n/aAU$781k

AU$15m

Mar 31 2022n/an/a

AU$18m

Dec 31 2021n/an/a

AU$22m

Sep 30 2021n/an/a

AU$26m

Jun 30 2021AU$2mAU$736k

AU$31m

Mar 31 2021n/an/a

AU$32m

Dec 31 2020n/an/a

AU$32m

Sep 30 2020n/an/a

AU$28m

Jun 30 2020AU$1mAU$635k

AU$23m

Mar 31 2020n/an/a

AU$22m

Dec 31 2019n/an/a

AU$21m

Sep 30 2019n/an/a

AU$21m

Jun 30 2019AU$876kAU$549k

AU$21m

Mar 31 2019n/an/a

AU$19m

Dec 31 2018n/an/a

AU$17m

Sep 30 2018n/an/a

AU$16m

Jun 30 2018AU$711kAU$489k

AU$15m

Mar 31 2018n/an/a

AU$15m

Dec 31 2017n/an/a

AU$15m

Sep 30 2017n/an/a

AU$15m

Jun 30 2017AU$50kAU$44k

AU$15m

Compensation vs Market: Ian's total compensation ($USD715.97K) is about average for companies of similar size in the Australian market ($USD785.25K).

Compensation vs Earnings: Ian's compensation has increased whilst the company is unprofitable.


CEO

Ian Kadish (60 yo)

6.8yrs

Tenure

AU$1,097,723

Compensation

Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...


Leadership Team

NamePositionTenureCompensationOwnership
Ian Kadish
CEO, MD & Director6.8yrsAU$1.10m0.24%
A$ 1.2m
Jacqueline Milne
Executive Director4.3yrsAU$1.05m0.011%
A$ 56.0k
Scott Paterson
Chief Financial Officerless than a yearno datano data
Julian Gully
Chief Information Officer4.5yrsno datano data
Nikki Valle
General Counsel & Company Secretaryless than a yearno datano data
Lisa Sorger
Chief Medical Officer2.7yrsno datano data

3.5yrs

Average Tenure

Experienced Management: IDX's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ian Kadish
CEO, MD & Directorno dataAU$1.10m0.24%
A$ 1.2m
Jacqueline Milne
Executive Director4.3yrsAU$1.05m0.011%
A$ 56.0k
Raelene Murphy
Independent Non-Executive Director6.4yrsAU$137.50k0.013%
A$ 68.7k
Andrew Fay
Independent Non-Executive Director1.7yrsAU$131.77k0.036%
A$ 188.7k
Ingrid Player
Independent Non-Executive Directorless than a yearno data0.015%
A$ 77.7k
James Hall
Independent Non-Executive Directorless than a yearno data0.064%
A$ 333.0k

1.7yrs

Average Tenure

58yo

Average Age

Experienced Board: IDX's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.